Mezzasalma Advisors, LLC Novo Nordisk A S Transaction History
Mezzasalma Advisors, LLC
- $233 Million
- Q2 2024
A detailed history of Mezzasalma Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mezzasalma Advisors, LLC holds 22,922 shares of NVO stock, worth $2.64 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
22,922
Previous 11,900
92.62%
Holding current value
$2.64 Million
Previous $1.53 Million
114.21%
% of portfolio
1.4%
Previous 0.72%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,988Shares Held
318MCall Options Held
5.16MPut Options Held
4.97M-
Jennison Associates LLC21.2MShares$2.44 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.68 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.63 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.54 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.44 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $260B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...